Shengdong Wu
Ningbo University(CN)Ningbo Medical Center Lihuili Hospital(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatic and Hepatic Oncology Research, Organ Transplantation Techniques and Outcomes, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma(2021)81 cited
- → Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance(2017)72 cited
- → Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection(2022)30 cited
- → Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma(2019)26 cited
- → IGF-1 contributes to liver cancer development in diabetes patients by promoting autophagy(2022)25 cited
- → Ro41-5253, a selective antagonist of retinoic acid receptor α, ameliorates chronic unpredictable mild stress-induced depressive-like behaviors in rats: Involvement of regulating HPA axis and improving hippocampal neuronal deficits(2019)23 cited